| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1025723 |
| landingPage: |
http://www.iedb.org/assay/1976184 |
| type: |
Literature
|
| publicationVenue: |
J Mol Biol
|
| dates: |
2013
|
| study type: | b cell assays |
| subject species: | Hepatitis C virus |
| fullName: |
Homer Pantua
Jingyu Diao
Mark Ultsch
Meredith Hazen
Mary Mathieu
Krista McCutcheon
Kentaro Takeda
Shailesh Date
Tommy K Cheung
Qui Phung
Phil Hass
David Arnott
Jo-Anne Hongo
David J Matthews
Alex Brown
Arvind H Patel
Robert F Kelley
Charles Eigenbrot
Sharookh B Kapadia
|
| method: |
biological activity
|
| name: |
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies.
|
| description: |
The epitope-specific antibody hu5B.v3 neutralized HCV genotype 2a (J6CF) and chimeric genotype 2a (Jc1; J6/C3). The humanized affinity matured antibody hu5B.v3 was more effective than the parent mouse antibody mu5B3. Mutations N417S, N417T and N415D in Jc1 HCVcc conferred resistance to neutralization, while mutation N417G remained sensitive.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |